PIM
WST icon

Plato Investment Management’s West Pharmaceutical WST Stock Holding History

Plato Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$900K Sell
2,522
-13
-0.5% -$3.97K 0.05% 287
2026
Q1 		$636K Hold
2,535
– – 0.04% 326
2025
Q4 		$701K Hold
2,535
– – 0.05% 313
2025
Q3 		$660K Buy
+2,535
New +$616K 0.04% 319
2024
Q3 		– Sell
-886
Closed -$292K – 580
2024
Q2 		$292K Hold
886
– – 0.03% 306
2024
Q1 		$351K Buy
+886
New +$328K 0.04% 287

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Plato Investment Management's WST Position: Q2 2026 in Review

Plato Investment Management reduced its West Pharmaceutical (WST) stake by 0.51% in Q2 2026, selling an estimated $3.97K and leaving 2,522 shares worth $900K. The position accounts for 0.05% of the portfolio, ranked #287.

Plato Investment Management first reported a position in WST in Q1 2024 and has held it in 6 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Plato Investment Management held 2,522 shares of West Pharmaceutical worth $900K as of Q2 2026.
  • Plato Investment Management sold 13 West Pharmaceutical shares in Q2 2026, an estimated $3.97K.
  • West Pharmaceutical made up 0.05% of Plato Investment Management's portfolio in Q2 2026, its #287 holding.
  • Plato Investment Management first reported a position in West Pharmaceutical in Q1 2024 and has held it in 6 quarters since.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Plato Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.